Difference between revisions of "WSI21-76-Case-3"

From MGH Learn Pathology
(Updating subject, access, and performer)
(Added status template)
 
Line 55: Line 55:
 
|subject=Z0FBQUFBQmdkTEVuLU5OZ1E4M3ZkVUUtc0RBUXBNOXA3eTRWWmk1VW1jcUJNeEpodG9iQ05Ub0ZIZjlFWE9mbU1VaG5Td1NSTUZXc2NYN0FrakpJQXVUNHF6clJQcElpTFoxYmxLZ096SktaX3NwMmhkbFN6ZmM9
 
|subject=Z0FBQUFBQmdkTEVuLU5OZ1E4M3ZkVUUtc0RBUXBNOXA3eTRWWmk1VW1jcUJNeEpodG9iQ05Ub0ZIZjlFWE9mbU1VaG5Td1NSTUZXc2NYN0FrakpJQXVUNHF6clJQcElpTFoxYmxLZ096SktaX3NwMmhkbFN6ZmM9
 
|modality=mrxs
 
|modality=mrxs
 +
}}
 +
{{status
 +
|status=active
 +
|requester=Rh27
 +
|authoredOn=April 12, 2021 08:40:24 PM
 
}}
 
}}

Latest revision as of 14:18, December 9, 2024

WSI21-76-Case-3
82 year-old female with history of chronic renal failure due to autoimmune disease; previous anemia of chronic disease on EPO therapy, now has become leukopenic and thrombocytopenic. WBC 0.6 x 109/L (23% polys, 66% lymphs, 11% eos), HGB 6.7 g/dL, PLT 13 x 109/L.
Methotrexate-induced transient myelosuppression and dysplasia
April 19, 2021 12:00:00 AM